SHSE •
Healthcare •
Biotechnology •
Quote as of 08/25/2026 15:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeSHSE
Market Capitalization7,077.87 mln
Float931 mln
EPS
0.13
Overpriced
P / E
33.00
Overvalued
Piotroski F-Score
2
/ 9
Weak
Beneish M-Score
-2.26
Borderline
1-Year Forecast
5.28
Attractive
Relative Strength
43
/ 100
Slightly lagging
Business Description
Founded in 1964 and headquartered in Zhaoqing, China, Star Lake Bioscience manufactures and sells a wide range of pharmaceutical ingredients and food and feed additives under the Star Lake and Yue Bao brands, serving both domestic and international markets. Its product portfolio includes amino acids used in medical treatments and animal nutrition, antiviral compounds targeting conditions such as Hepatitis B, and nucleotide-based substances applied in food processing and the treatment of blood and liver disorders. The company also supplies a broad selection of other active ingredients used across the pharmaceutical and food industries.